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NZB  and  (NZB  X  NZW)F1  (B/W)  mice  resist  the  induction  of immunologic 
tolerance  in  vivo  under  certain  conditions  (1-3)  but  not  others  (4,  5).  Adoptive 
transfer studies in such mice have indicated a  resistance to tolerance induction at the 
T  cell level (6,  7).  Although NZB and B/W bone marrow-derived lymphocytes have 
been  reported  to  display  normal  tolerance  susceptibility  (7-9),  an  age-dependent 
resistance  to  tolerance  induction  by bovine  gamma  globulin  (BGG)  in  B/W  bone 
marrow cells has been reported  (8). In view of these divergent findings, as well as the 
more recent  documentation  of various B  cell  abnormalities  in  NZB and  B/W  mice 
(10-12),  we have reexamined  B  cell  tolerance  in  B/W  mice in  an  entirely  thymus- 
independent, in vitro system. With the tolerogen trinitrophenyl (TNP) human gamma 
globulin  (HGG)  (13), we report here that splenic B cells derived  from B/W mice are 
less susceptible than B cells from three strains of normal mice to tolerance induction 
by a  tolerogen with low, but not high, epitope density. 
Materials  and Methods 
Animals.  BDFx (C57BL/6 female X DBA/2 male F1) (TheJackson Laboratory, Bar Harbor, 
Maine; Cumberland View Farms, Clinton, Tenn.; and Simonsen Laboratories, Gilroy, Calif.), 
CBA/J, and DBA/1J (The Jackson Laboratory) mice, 8-12 wk of age, were used in this study. 
7-  to  12-wk-old  B/W  mice  were  obtained  from  our  colony  at  the  University  of Texas 
Southwestern Medical School (Dallas, Tex.). B/W mice bred from NZB and NZW mice, kindly 
provided by Dr. Alfred Steinberg, National Institutes of Arthritis,  Metabolism, and Digestive 
Diseases,  National Institutes of Health, Bethesda, Md., were also tested. 
Antigens.  HGG Cohn fraction II, (Miles  Laboratories, Inc., Elkhart, Ind.) was haptenated 
with 2,4,6-trinitrobenzene sulfonic acid (Sigma Chemical Co., St.  Louis, Mo.) at substitution 
ratios of TNPa~HGG  (high epitope  density tolerogen)  and  TNPTHGG (low epitope  density 
tolerogen)  as determined spectrophotometrically. TNP-Brucella abortus (BA) was prepared  as 
described previously (13). Heat-killed BA (U. S. Department of Agriculture, Ames, Iowa) was 
haptenated with fluorescein isothiocyanate (FITC) (Isomer I; Sigma Chemical Co.) as follows: 
40 mg of FITC was added to 0.25 ml of  washed, packed bacterial cells in carbonate/bicarbonate 
buffer, pH 9.2. The suspension was incubated at 26°C for 1 h before centrifugation (12,000 g 
for  10 min).  The fluorescein  (FL)-BA pellet  was washed  five  times  in  Hanks' balanced  salt 
solution (HBSS) (Microbiological Associates,  Walkersville, Md.). 
Plaque-forming Cells (PFC) Assay.  PFC were determined by a slide modification (14) of the 
hemolysis in gel technique (15). TNP-BA-stimulated euhures were assayed against TNP-sheep 
erythrocytes (SRBC) (16); FL-BA-stimulated cultures were assayed against FL-SRBC (17). 
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Induction and Assessment of Unresponsiveness.  Pooled spleen  cells  derived  from four or more 
syngeneic mice were treated with a monoclonal anti-Thy-l.2 reagent  (New England Nuclear, 
Boston, Mass.)  and guinea pig complement (Pel-Freeze Biologicals Inc., Rogers, Ark.)  to kill T 
cells.  The  proliferative  responses  of treated  cells  to  T  cell  mitogens  (concanavalin  A  and 
phytohemagglutinin)  were  abolished  entirely,  whereas  responsiveness  to  lipopolysaccharide 
remained intact. The cells were washed and cultured at  10  7 cells/ml in complete medium (13, 
18) in the presence of log dilutions ofeither high or low epitope density tolerogens as previously 
described or underivatized HGG at  1 #g/ml  (control) for 20-24 h on a rocker platform. The 
cells  were  then  harvested,  washed  three  times  with  HBSS,  and  resuspended  in  complete 
medium.  5  ×  10  s  viable  cells  were  placed  in  microtiter  wells  (Costar,  Data  Packaging, 
Cambridge, Mass.)  to which 1 ×  106 fresh,  unprimed, syngeneic x-irradiated  (1,500  R) spleen 
cells were added as filler  cells. The cultures were immunized with either 0.00VT~ TNP-BA or 
0.001% FL-BA (vol/vol). After 3 d of incubation with antigen, direct anti-hapten PFC responses 
were assayed. The results of three to six replicate cultures are expressed as the arithmetic mean 
PFC response per 106 viable input B cells :t: SE or as percent control PFC response. 
Statistics.  Four mouse strains were compared for tolerance susceptibility by using a three- 
factor analysis of variance with strain  and  tolerogen concentration as fixed factors and  cell 
sample as a random factor nested within strain (19). When significance was attained, particular 
comparisons were made with Newman-Keuls multiple comparison procedure (19). 
Results 
As shown in Fig.  1 A, in pooled data from three to six experiments,  0.1-1.0 #g/ml 
of the high epitope density tolerogen induced 50% unresponsiveness to TNP in B cells 
from (autoimmune) B/W, and (normal) BDF1, CBA/J, and DBA/1J mice. Statistical 
analysis revealed no significant difference between the strains at any concentration of 
the high epitope  density tolerogen.  Exposure to TNP32HGG did  not affect  the anti- 
FL  response  (Fig.  1  C),  thus  indicating  that  the  tolerance  was  hapten  specific. 
Furthermore,  addition  of the high epitope  density tolerogen  to B  cells at  the end of 
the  24-h tolerance  induction  period  did  not  depress  the control  response  by >20%. 
Thus, the tolerance observed required  the generation  of a  time-dependent  off-signal 
and  was  not  a  result  of passive  carry over of the  tolerogen  into  the  immunization 
phase of the cultures. 
In contrast, when the same cells were exposed to the low epitope density tolerogen, 
the analysis of variance procedure  yielded  a  significant  difference  among strains  (P 
<  0.0001).  With the multiple comparison techniques at a  ~- 0.05, B/W mice differed 
significantly  from each of the  three  normal  strains,  and  the  normal  strains  did  not 
differ  significantly  from  each  other  in  B  cell  tolerance  susceptibility  (Fig.  1  B). 
Exposure  of cells  to TNP7HGG  reduced  the  control  anti-TNP  response  by 50%  or 
more in each of the normal strains, but only 25% or less in B/W mice. A representative 
experiment  is  shown  in  Fig.  2.  Of note,  the  resistance  to  the  low  epitope  density 
tolerogen was evident when B cells from either male or female B/W mice were tested 
independently. 
Discussion 
The present  studies  demonstrate  that  B  cells  derived  from spleens  of adult  B/W 
mice are resistant  to tolerance induction when the epitope density of the tolerogen is 
low. Thus, when TNPa2HGG was used, B cells from three normal mouse strains and 
B/W  mice  were  not  significantly  different  in  tolerance  susceptibility.  In  contrast, 
when TNP7HGG was used, cells from B/W mice were significantly less sensitive than 
those from normal mice to the induction of B cell tolerance in vitro. 732  GOLDINGS  ET AL.  BRIEF  DEFINITIVE REPORT 
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Fio.  I.  Dose  effect oftolerogens with either (A) high (TNPmHGG) or (B) low (TNPTHGG) epitope 
density on the anti-TNP  PFC responses of B/W (I), BDFI (l~), CBA/J ([]), and DBA/1J (r-I) B 
cells, Arithmetic mean control anti-TNP  PFC/106 3= 1 SE: B/W, 730 3= 283; BDF,, 1,387 3= 640; 
CBA/J,  2,605 3=  380  and  DBA/1J,  1,838 +  164. (C)  Anti-FL  responses of cells exposed to 
TNPmHGG. Arithmetic mean control anti-FL PFC/10  s 3= 1 SE: B/W, 454 3= 365; BDFj, 457 + 
285; CBA/J, 335 3= 118; and DBA/IJ, 225 3= 52. 
Previous studies  have shown  a  striking  relationship  between  epitope  density  and 
tolerogenicity vs. antigenicity for hapten conjugates of proteins  (20), polysaccharides 
(21),  amino acid copolymers  (21),  immunoglobulin  G  (22,  23),  and  liposomes  (24). 
Highly substituted  conjugates are consistently tolerogenic, whereas those with lower 
substitution  ratios are immunogenic or have no detectable effect. In agreement with 
these reports is the present  study, which documents that TNPTHGG is,  to a  varying 
degree, a less potent tolerogen than TNP~2HGG for normal mouse B cells. Moreover, 
this  is  the  first  report  to examine  directly the  relationship  between  epitope  density 
and  tolerogenicity  in  B  cells  from  (autoimmune)  B/W  mice and  to demonstrate  a 
significant functional difference between these and B cells of normal mice. 
Previous reports of B cell tolerance in autoimmune mice have relied on the adoptive 
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FIG. 2.  A representative experiment showing the anti-TNP response of (A) BDF1 or (B) B/W B 
cells after exposure to TNP-HGG with either high (0) or low (O) epitope density. 
syngeneic thymocytes (7,  8).  In no study was the  bone marrow depleted  of T  cells 
before transfer. The susceptibilities of B/W or (NZB ×  BALB/c)Ft bone marrow to 
the induction of high zone tolerance by SRBC with (7) or without  (9)  facilitation by 
cyclophosphamide proved to be entirely normal.  Similarly, bone marrow appeared 
normally susceptible  to  tolerance  induction  by both  pneumococcal  polysaccharide 
(SIII) and levan (9).  However, the tolerance susceptibility to BGG was normal only 
when cells from young (3-wk-old), but  not  adult  (3- to 4-mo-old), mice were tested 
(8). 
The present  findings  of normal  B  cell  tolerance  in  B/W  mice with  muhivalent, 
high,  but not  low, epitope density tolerogens suggest an explanation  for the diverse 
outcomes in previous bone marrow transfer experiments. If, as in the case of various 
polysaccharide antigens, the epitopes are presented  in a  muhivalent array, it would 
not be surprising that TNP3~HGG and SRBC are effective tolerogens for B cells of B/ 
W  mice. On the other hand, uhracentrifuged, monomeric BGG might be expected to 
behave as  a  low  epitope  density  tolerogen.  Thus,  the  B/W  resistance  to  tolerance 
induction  by TNPTHGG would be consistent with previously observed resistance to 
BGG-induced unresponsiveness. 
In conclusion, B cells from adult  B/W mice are abnormally resistant  to tolerance 
induction  by TNPTHGG, perhaps  as  a  consequence  of prior polyclonal  activation 
(including  TNP-specific clones)  (10-12,  25).  A  similar  loss  of the  susceptibility  to 734  GOLDINGS ET  AL.  BRIEF DEFINITIVE REPORT 
tolerance induction in B  cells to self-antigens with low epitope density might  lead to 
autoantibody formation and disease. 
Summary 
Hapten-specific tolerance was  induced  in  vitro by  trinitrophenyl-human  gamma 
globulin  (TNPa2HGG)  to  a  comparable  degree  in  B  cells from  adult  autoimmune 
(NZB ×  NZW)F1 (B/W) mice and normal BDF1, CBA/J, and DBA/1J  mice. When 
a lower epitope density tolerogen (TNPTHGG)  was used, B/W mice were significantly 
less sensitive than  normal  mice to the induction of B  cell tolerance. This  finding of 
defective B  cell tolerance in adult B/W  mice is consistent with previous reports that 
document other B cell abnormalities that may relate to the expression ofautoimmune 
disease. 
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